For the first time a multicentre study, including data from all around Spain, shows that telemedicine reduced in a 50% the economic impact of visits to the hospital in patients with type 1 diabetes mellitus. It spares time to the patient, and also to the healthcare professional. This is demonstrated by the preliminary results of the Telemed-Diabetes Study, conducted by the Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) funded by the Institute of Health Carlos III (Ministry of Economy and Competitiveness), which were presented last Saturday at the XXIV Congress of the Spanish Society of Diabetes, held in Seville. Dr. Enric Esmatjes, IDIBAPS researcher at the Diabetes: metabolic and molecular networks team and Head of Diabetes Unit at Hospital Clínic of Barcelona, coordinates this study evaluating the cost-effectiveness of telematic systems applied to the treatment of type 1 diabetes mellitus.
Information via: CIBERDEM